Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas

Nanni, Cristina; Marzola, Maria Cristina; Rubello, Domenico; Fanti, Stefano

doi:10.1007/s00259-009-1222-x

Cited by 7 publications

(3 citation statements)

References 14 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, 18 F-FDG-PET/CT is now used for noninvasive assessment of response to chemotherapy in many tumors in adults and children [9][10][11][12][13]. With regard to bone and soft tissue sarcomas, several studies have found a correlation between 18 F-FDG uptake after chemotherapy and both survival and tumor histopathological response [11][12][14][15][16][17].…”

Section: Primary Tumor Bone Metastasismentioning

confidence: 99%

“…Recent studies have shown that, if conventional imaging modalities (CIM) remain the staging reference, positron emission tomography/computed tomography using fluorine-18-fluorodeoxyglucose ( 18 F-FDG-PET/CT) provides additional information for evaluation of initial disease [5][6][7][8]. This metabolic imaging modality also proved its impact in the evaluation of response to chemotherapy, particularly in hematological tumors in adults and children and in some bone sarcomas [9][10][11][12][13].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas

Eugène

Corradini

Carlier

et al. 2012

Nuclear Medicine Communications

View full text Add to dashboard Cite

show abstract

Section: Primary Tumor Bone Metastasismentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas

Eugène

Corradini

Carlier

et al. 2012

Nuclear Medicine Communications

View full text Add to dashboard Cite

show abstract

“…Fluorodeoxyglucose-18 ( 18 F-FDG) is the most commonly used radionuclide. In a recent publication, diagnostic and prognostic of PET/CT in sarcoma were considered highly sensitive and specific in the detection of STS (17) and RPS (18). Furthermore, the SUVmax of the primary tumor was a strong predictor of survival (19).…”

Section: Imaging Workupmentioning

confidence: 99%

A critical narrative review of radiotherapy for retroperitoneal soft tissue sarcoma

et al. 2020

View full text Add to dashboard Cite

Retroperitoneal sarcomas (RPSs) are rare diseases, and the 5-year overall survival rate remains low. Management of RPSs is challenging, and the quality of treatment strategy is a crucial prognostic factor.Treatment decisions and the treatment department to which the patients is referred must be centralized.Overall survival rate is positively correlated with the number of patients treated in the centers. En bloc surgery is the standard of care for effective treatment and potential for cure, whereas perioperative chemotherapy or radiotherapy has not yet been validated. Pre-or postoperative radiotherapy was considered controversial, but the STRASS trial publication illustrated that preoperative radiation could be useful in some conditions.Retroperitoneal liposarcoma might become a future target of prospective trials. Furthermore, some retrospective studies have shown that preoperative radiotherapy increases the rate of R0-R1 resections. This article reviews the role of external beam radiotherapy in the management of RPS and highlights the optimal volumes, doses, and radiotherapy techniques for the treatment of RPS. As accurately predicting prognosis in patients with RPS is challenging, we also emphasize the utility of nomograms in the field of radiotherapy.However, these nomograms do not include radiotherapy as a predictive factor. Although some authors could conclude that use of radiotherapy should be avoided based on the results of the STRASS trial, some data argue that radiotherapy still has utility in select cases.

show abstract

Inflammation

Santiago

2014

Positron Emission Tomography With Computed Tomography (PET/CT)

View full text Add to dashboard Cite

Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas

Cited by 7 publications

References 14 publications

18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas

18F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas

A critical narrative review of radiotherapy for retroperitoneal soft tissue sarcoma

Inflammation

Contact Info

Product

Resources

About